|Full Name||carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15|
|Product Description||Rabbit Polyclonal antibody to CHST15 (carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15)|
|Background||Sulfotransferase that transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the C-6 hydroxyl group of the GalNAc 4-sulfate residue of chondroitin sulfate A and forms chondroitin sulfate E containing GlcA-GalNAc(4,6-SO(4)) repeating units. It also transfers sulfate to a unique non-reducing terminal sequence, GalNAc(4SO4)-GlcA(2SO4)-GalNAc(6SO4), to yield a highly sulfated structure similar to the structure found in thrombomodulin chondroitin sulfate. May also act as a B-cell receptor involved in BCR ligation-mediated early activation that mediate regulatory signals key to B-cell development and/or regulation of B-cell-specific RAG expression; however such results are unclear in vivo. |
|Synonyms||BRAG antibody, DKFZp781H1369 antibody, GALNAC4S-6ST antibody, KIAA0598 antibody, MGC34346 antibody, RP11-47G11.1 antibody, CHST15 antibody, B cell RAG associated protein (GALNAC4S-6ST) antibody, B-cell RAG-associated gene protein antibody, carbohydrate sulfotransferase 15 antibody, N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase antibody, hBRAG antibody, carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 antibody|
|Cellular Localization||Golgi apparatus membrane; Single-pass type II membrane protein (Probable) |
|Immunogen||Recombinant protein encompassing a sequence within the center region of human CHST15. The exact sequence is proprietary.|
|Predicted Cross Reactivity species Predicted cross-reactivity:|
Predicted cross-reactivity is based on sequence homology, with greater than 80% immunogen sequence identity considered positive.
Please note that we are only able to guarantee products to work in applications and species in which they have been tested.
|Predict Reactivity Note||Mouse (94%), Rat (94%)|